logo
Select company
Select metric
$ -1.27EBITDA per Share
VS
Market
16
Sector
42
Industry
34
History
3
$ 4.49Close
$ 1.71 - $ 12.7 52-Week Range
Ticker Information

Ticker

CATX

Company Name

PERSPECTIVE THERAPEUTICS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NYSEMKT

PERSPECTIVE THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CATX - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -94.03M$ -1.27174.23M
3/31/2025$ -84.47M$ -1.17172.36M
12/31/2024$ -79.02M$ -1.23164.42M
9/30/2024$ -53.78M$ -0.76170.63M
6/30/2024$ -49.45M$ -0.74166.65M
3/31/2024$ -49.22M$ -0.99149.51M
12/31/2023$ -48.01M$ -1.79126.76M
9/30/2023$ -34.7M$ -1.24128.06M
6/30/2023$ -28.67M$ -1.02128M
3/31/2023$ -19.84M$ -0.87122.86M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PERSPECTIVE THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -0.46.
  • Over the past 5 years, PERSPECTIVE THERAPEUTICS INC's average EBITDAPS has been $ -0.77.
  • The median EBITDAPS for PERSPECTIVE THERAPEUTICS INC during this period was $ -0.74
  • PERSPECTIVE THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -0.27.
  • The lowest EBITDAPS recorded by PERSPECTIVE THERAPEUTICS INC in the same timeframe $ -1.79

PERSPECTIVE THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
RNAC : CARTESIAN THERAPEUTICS INC $ -1.22INBX : INHIBRX BIOSCIENCES INC $ -9.91NWBO : NORTHWEST BIOTHERAPEUTICS INC $ -0.05HUMA : HUMACYTE INC $ -0.26SI : SHOULDER INNOVATIONS INC -PAVM : PAVMED INC $ 4.05CODX : CO-DIAGNOSTICS INC $ -1.05MGRM : MONOGRAM TECHNOLOGIES INC $ -0.49MREO : MEREO BIOPHARMA GROUP PLC $ -0.31CV : CAPSOVISION INC -

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for PERSPECTIVE THERAPEUTICS INC is calculated as follows: EBITDA [ $ -3.16M ] / (Shares WA [ 6.89M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -0.46 ]

CATX - EBITDA per Share, Last 5 years

$ -1.79

Minimum

Dec 31, 2023

$ -0.27

Maximum

Mar 31, 2021

$ -0.77

Average

$ -0.74

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26